Edgemond James's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jun 10, 2025
- Accession no.
- 0001562180-25-004681
- Filed
- Jun 10, 2025
- Trade date
- Jun 9, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.90M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edgemond JamesCIK 0001636178 | Officer (CFO AND TREASURER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2025 | Common Stock | MOption exerciseAcquired | +12,000 | $117.76 | +$1,413,120 | 20,118 | Direct | |
| Jun 9, 2025 | Common Stock | SSaleDisposed | −3,595 | $325.44F2 | −$1,169,956.8 | 16,523 | Direct | |
| Jun 9, 2025 | Common Stock | SSaleDisposed | −305 | $326.56F3 | −$99,600.8 | 16,218 | Direct | |
| Jun 9, 2025 | Common Stock | SSaleDisposed | −100 | $328.28 | −$32,828 | 16,118 | Direct | |
| Jun 9, 2025 | Common Stock | SSaleDisposed | −7,700 | $325.20F4 | −$2,504,040 | 8,418 | Direct | |
| Jun 9, 2025 | Common Stock | SSaleDisposed | −300 | $326.81F5 | −$98,043 | 8,118 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2025 | Common Stock | MOption exerciseDisposed | −12,000 | $0.00 | $0 | 87,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $325.00 to $325.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $326.04 to $326.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $325.00 to $325.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $326.57 to $327.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.